Cargando…

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer

Background: Emerging evidence suggests that the immune system plays a crucial role in the regulation of the response to therapy and long-term outcomes of patients with breast cancer (BRCA). In this study, we aimed to identify a significant signature based on immune-related genes to predict the progn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Jianying, Li, Yan, Su, Tianxiong, Zhang, Qiaomei, He, Xin, Tao, Dan, Wang, Yanyun, Yuan, Manqiu, Li, Yanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526716/ https://www.ncbi.nlm.nih.gov/pubmed/33193571 http://dx.doi.org/10.3389/fgene.2020.00912

Ejemplares similares

CD40LG as a Prognostic Molecular Marker Regulates Tumor Microenvironment Through Immune Process in Breast Cancer
por: Yuan, Manqiu, et al.
Publicado: (2021)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma
por: Zhang, PeiPei, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma
por: Tian, Jun, et al.
Publicado: (2021)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer
por: Wang, Bofang, et al.
Publicado: (2022)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
por: Chen, Yun
Publicado: (2022)

Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes
por: Peng, Gaoge, et al.
Publicado: (2022)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Identification of immune signatures in Parkinson’s disease based on co-expression networks
por: Dong, Xiaolin, et al.
Publicado: (2023)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021)

Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis
por: Wang, Xue-quan, et al.
Publicado: (2021)

Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea
por: Peng, Lu, et al.
Publicado: (2021)

Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer
por: Cai, Jiehui, et al.
Publicado: (2022)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma
por: Li, Junwu, et al.
Publicado: (2022)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm
por: Zhou, Zhiyang, et al.
Publicado: (2022)

Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer
por: Li, Jingtai, et al.
Publicado: (2023)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Tang, Qiang, et al.
Publicado: (2022)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022)

Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer
por: Gao, Shengnan, et al.
Publicado: (2022)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
por: Sun, Hengzi, et al.
Publicado: (2019)

Identification and Validation of a Five-Gene Diagnostic Signature for Preeclampsia
por: Liu, Yu, et al.
Publicado: (2022)

Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer
por: Wang, Qian, et al.
Publicado: (2022)

Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma
por: Hong, Peng, et al.
Publicado: (2022)

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6fkegiln8f8vc3lj18c64v14t7